VIDAS Lyme IgG II assay is a qualitative immunoassay intended for use on VIDAS
VIDAS Lyme IgG II assay is a qualitative immunoassay intended for use on VIDAS family instrument in the presumptive detection of human IgG antibodies to Borrelia burgdorferi.
VIDAS Lyme IgM II assay is an automated qualitative enzyme immunoassay intended
VIDAS Lyme IgM II assay is an automated qualitative enzyme immunoassay intended for use on VIDAS family instrument for detection of human IgM antibodies to Borrelia burgdorferi.
The VIDAS ® Lyme IgG and IgM assay for use on VIDAS family instruments for the
The VIDAS ® Lyme IgG and IgM assay for use on VIDAS family instruments for the presumptive detection of total antibodies (IgG/IgM) to Borrelia burgdorferi
AccuDiag ™ Borrelia burgdorferi IgG/IgM is an enzyme-linked immunosorbent assay
AccuDiag ™ Borrelia burgdorferi IgG/IgM is an enzyme-linked immunosorbent assay (ELISA) for the qualitative presumptive detection of total (IgG and IgM) antibodies to Borrelia burgdorferi in human serum. This ELISA should only be used for patients with signs and symptoms that are consistent with Lyme disease. Equivocal or positive results must be supplemented by testing with a standardized Western blot procedure. Positive supplemental results are supportive evidence of exposure to B. burgdorferi and can be used to support a clinical diagnosis of Lyme disease.
The ZEUS ELISA Borrelia VlsE1/pepC10 IgG/IgM Test System is intended for the qua
The ZEUS ELISA Borrelia VlsE1/pepC10 IgG/IgM Test System is intended for the qualitative detection of IgG and IgM class antibodies to VlsE1 and pepC10 antigens from Borrelia burgdorferi in human serum. The assay is intended for testing serum samples from symptomatic patients or those with a history of Lyme Borreliosis. All positive and equivocal specimens should be tested with a second-tier test such as Western Blot, which if positive, is supportive evidence of infection with Borrelia burgdorferi. Diagnosis of Lyme Borreliosis should be made based on the presence of B. burgdorferi antibodies, history, symptoms, and other laboratory data. Negative first or second tier results should not be used to exclude Borreliosis. This assay is for In Vitro diagnostic use.
ELISA Borrelia VlsE1/pepC10 IgG/IgM Smart Kit Test System
The ImmunoDOT Borrelia (Lyme) test is an enzyme immunoassay (EIA) dot-blot test
The ImmunoDOT Borrelia (Lyme) test is an enzyme immunoassay (EIA) dot-blot test for the qualitative detection of Borrelia antibodies. Both species specific (anti-P39) and related Borrelia burgdorferi antibodies (IgG, IgM, and IgA) are detected in serum as an aid in the diagnosis of Lyme disease.
This serum control contains IgG antibodies specific to Borrelia burgdorferi, the
This serum control contains IgG antibodies specific to Borrelia burgdorferi, the causative agent of Lyme Disease, and is to be used in conjunction with the appropriate ImmunoDOT Assay Test System.
The ImmunoWELL Borrelia (Lyme) Test is an enzyme immunoassay (EIA) for the quali
The ImmunoWELL Borrelia (Lyme) Test is an enzyme immunoassay (EIA) for the qualitative and/or semi-quantitative detection of Borrelia burgdorferi total antibodies (IgG, IgM, and IgA) in serum and is used as an aid in the diagnosis of Lyme disease.